A panel of scientists has revised the guidelines that physicians use to prescribe medication for patients infected with human immunodeficiency virus.
The new guidelines include starting antiretroviral drugs, which are designed for the class of viruses that include HIV, when a patient’s CD4 T cell count dips below 350 per cubic millimeter of blood, down from the past standard of 500 T cells/mm3.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.